Researchers develop treatment for vancomycin-resistant bacteria
Researchers from several institutions have developed a treatment for bacteria resistant to vancomycin, which is…
March 9, 2023 - 4 minutes
Infectious disease
Beyond Biotech podcast 37: Natural killer cells, biopharma revenue, toxic shock syndrome vaccine
This week our guests are Marit Inngjerdingen from the Institute of Clinical Medicine in Norway;…
March 9, 2023 - 3 minutes
Lipid fingerprint could help TB treatment
A new method that measures the amounts of drugs and lipids in individual cells could…
February 16, 2023 - 2 minutes
First toxic shock syndrome vaccine phase 2 study completed
The first vaccine to potentially prevent Staphylococcal-induced toxic shock syndrome (TSS) has successfully completed a…
February 9, 2023 - 4 minutes
AAHI bags $9.9M to develop nasal spray influenza RNA vaccine
The Access to Advanced Health Institute (AAHI) has been awarded a project agreement worth up…
February 7, 2023 - 3 minutes
Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation
Infex Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted qualified…
January 4, 2023 - 2 minutes
Blacksmith Medicines merging with Forge Therapeutics
Blacksmith Medicines, Inc., and Forge Therapeutics have signed a definitive merger agreement. This will create…
January 3, 2023 - 2 minutes
Watch: Valo Therapeutics at Bio-Europe
Valo Therapeutics Oy is a Finnish immunotherapy company developing antigen-coated oncolytic viruses and vaccine vectors…
December 20, 2022 - 1 minute
Swedish research center expanding to take on antimicrobial resistance
Research on antibiotic resistance will get a boost when the Center for Antibiotic Resistance Research…
December 16, 2022 - 3 minutes
Providence Therapeutics’ mRNA rabies vaccine hits milestone
Providence Therapeutics Holdings Inc. says its new mRNA vaccine program for rabies post-exposure prophylaxis has…
December 16, 2022 - 2 minutes
MinervaX raises €72M to develop Group B Streptococcus vaccine
MinervaX ApS, a privately held Danish biotech company developing a novel vaccine against Group B…
December 15, 2022 - 2 minutes
Is an HIV Cure Possible? The Future of HIV Therapy
HIV research has come a long way since the virus was discovered in the…
December 1, 2022 - 8 minutes
